Human Albumin Takeda (Human Serum Albumin)

Human Albumin Takeda is indicated for conditions where plasma volume expansion is required. It is commonly employed in the following clinical situations:

• Management of hypovolemia due to trauma, hemorrhage, or dehydration
• Treatment of shock, including septic or hypovolemic shock
• Support during major surgery or extensive burns
• Adjunct therapy for plasma volume expansion in patients with liver disease or hypoalbuminemia
• Resuscitation in patients undergoing massive transfusion protocols

• Human Albumin Takeda increases plasma oncotic pressure by providing exogenous albumin, the principal plasma protein responsible for maintaining intravascular fluid balance. The elevated oncotic gradient draws water from the interstitial and intracellular compartments into the vascular space, thereby expanding intravascular volume and enhancing tissue perfusion without directly affecting cardiac contractility or vascular tone.

Human Albumin Takeda may be associated with adverse reactions ranging from mild to severe. Monitoring for these events is recommended during and after administration.

Common

• Mild fever or chills
• Transient hypotension or hypertension
• Headache or dizziness
• Nausea or vomiting
• Local irritation at the infusion site

Serious

• Anaphylactic or severe allergic reactions
• Volume overload leading to pulmonary edema
• Hemolysis or renal impairment
• Coagulopathy or thrombosis
• Transmission of infectious agents (rare)

Human Albumin Takeda should be used with careful clinical assessment and monitoring. Important precautions include:

• Assess fluid status and cardiac function before infusion to avoid volume overload
• Use caution in patients with renal or hepatic impairment, as albumin metabolism may be altered
• Monitor for signs of allergic reaction, especially in individuals with a history of serum protein sensitivity
• Adjust dosage in patients with severe hypoproteinemia or malnutrition
• Avoid rapid infusion rates that may precipitate hypotension or cardiovascular stress
• Ensure proper storage and handling to maintain sterility and potency

Human Albumin Takeda may interact with other therapies, influencing efficacy or safety. Consider the following:

Avoid

• Concurrent use of high‑dose diuretics that may exacerbate hypovolemia
• Simultaneous administration of other volume expanders without adjusting total fluid balance

Use with caution

• Vasopressors, as changes in intravascular volume can affect hemodynamic response
• Anticoagulants, because volume expansion may alter coagulation parameters
• Nephrotoxic drugs, given the potential for renal stress in volume‑overloaded states
• Blood products, to prevent additive volume overload